Use the Search Fields to Find Information
Page 126 of 374
Medicinal cannabis in the treatment of chronic pain
Abstract Background: Chronic pain is a major health issue, adversely affecting millions of Australians and costing billions of dollars annually. Current pharmaceutical treatments may be
May 21, 2024
Medicinal cannabis in the management of anxiety disorders: A systematic review
Abstract Background With rising anxiety disorder diagnoses, many individuals are seeking alternatives to standard pharmacotherapies, like medicinal cannabis. This systematic review focuses exclusively on anxiety-related
November 7, 2025
Medicinal cannabis in neurodegenerative disorders: an open label, dose finding, safety and efficacy study
Please use this link to access this publication. Abstract Aim: Currently, there exist no curative treatments for neurodegenerative disorders. Recently, there has been a resurgence of
September 5, 2024
Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review
Please use this link to access this publication. Abstract Background: Autism spectrum disorder (ASD) is a neurodevelopmental condition estimated to affect 1 in 66 children in
October 30, 2024
Medicinal cannabis improves sleep in adults with insomnia: a randomised double-blind placebo-controlled crossover study
Abstract Insomnia or difficulty falling and or staying asleep is experienced by up to 30% of the general population. This randomised crossover double-blind placebo-controlled 6-week
September 5, 2024
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence
Abstract Background: Cannabis-based medicinal products (CBMPs) are increasingly being used to treat post-traumatic stress disorder (PTSD), despite limited evidence of their efficacy. PTSD is often comorbid
Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation
Abstract Introduction: Medicinal cannabis is prescribed in Australia for patients with chronic refractory pain conditions. However, measures of safety and effectiveness of different cannabinoids are lacking.
March 13, 2024
Medicinal Cannabis for the Treatment of Anxiety Disorders: a Narrative Review
Abstract Purpose of review Anxiety is a prevalent mental health condition which manifests as a disproportionate response of fear to a perceived threat. Different types
February 28, 2024
Medicinal cannabis for the treatment of anxiety disorders
Please use this link to access publication Abstract Background: Anxiety is second most common reason for medicinal cannabis prescription in Australia and is being treated
February 8, 2024
Page 126 of 374